Navigation Links
New Competent Cells for Highest Transformation Efficiencies

Up to 25-fold higher transformation efficiency of ligated DNA

Bruce Jerpseth Marie Callahan Alan Greener
Stratagene Cloning Systems, Inc.

Stratagenes new, high-efficiency competent E. coli cell line significantly improves the transformation efficiency of ligated DNA. Epicurian Coli XL10-Gold ultracompetent cells* yielded transformation efficiencies for ligated DNA that were up to 25-fold higher than other commercially available cell lines. XL10-Gold cells are the host cells of choice for any cloning experiment that requires a high efficiency of retrieving transformants from ligation reactions, such as constructing plasmid libraries and PCR cloning.

The ability to efficiently introduce DNA into E. coli by chemical transformation and electroporation is a key step for many procedures, such as generating plasmid libraries, cloning large DNA fragments and cloning PCR products.1 The cells that have set the industry standard for these types of procedures are Stratagenes ultracompetent cells, which yield greater than 5 x 109 transformants/g of supercoiled pUC18 vector (2.7 kb). However, these transformation efficiencies are typically calculated using very small amounts of supercoiled pUC18 vector DNA. Ligated DNA molecules are known to transform cells at a significantly lower efficiency than supercoiled molecules, and large plasmids transform cells less efficiently than small plasmids. This observation has particular impact for researchers making plasmid libraries: the total number and size distribution of primary transformants is key to finding the gene of interest and affects how easily full-length clones can be located. The bias against transforming larger molecules influences the ability to retrieve full-length cDNA clones. For example, many plasmid library vectors, including two-hybrid vectors and eukaryotic expression
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. An Epitope Tagging Vector for Gene Expression in Mammalian Cells
2. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
3. Cell Proliferation Kit Outperforms the Competition in the Range of Cells Typically Counted
4. XL10-Gold Cells Supplied in New Single-Reaction Format
5. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection
6. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
7. Simple Isolation of RNA from Tissue and Cultured Cells
8. New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes
9. TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins
10. Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells
11. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Competent Cells for Highest Transformation Efficiencies

(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... CARLOS, Calif., Dec. 14 Nektar Therapeutics ... Winger has been appointed to serve on its ... biopharmaceutical industry leader with over 35 years of ... ,, "Dennis brings to Nektar extensive industry perspective ... said Howard W. Robin, President and CEO of ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... ARLINGTON, Va., March 17 The 2008 Life ... Boston Waterfront Hotel on June,3, 2008 at a ... Leading market research firm,BioInformatics, LLC ( http://www.gene2drug.com ) ... this year,s awards., The annual awards honor ...
... Inc., a developer of advanced medical devices for ... that it has enrolled its,first patient in the ... prospective,multi-centered U.S. registry study of the company,s OmniWave(TM),Endovascular ... acute deep vein thrombosis (DVT). All patients enrolled ...
... 17 Alimera Sciences,and pSivida Ltd (Nasdaq: ... that,they have amended their license and collaboration agreement ... treatment for,diabetic macular edema (DME), and other Medidur ... profits of Medidur FA from 50 to 80,percent ...
Other Biology Technology:Life Science Industry Awards to Be Announced June 3, 2008 in Boston 2Life Science Industry Awards to Be Announced June 3, 2008 in Boston 3First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 2Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 3Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement 4
(Date:12/14/2009)... feature of humans. That,s until examples of tool use came ... of other mammals. Now, a report in the December 14th ... adds an octopus to the growing list of tool users. ... that the researchers call stilt walking. In it, the soft-bodied ... its eight arms rigid, and raises the whole assembly to ...
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3TV Interferes With Infants Language Development 47700 1TV Interferes With Infants Language Development 47700 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 1Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 3Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 5Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
... in a population because predators detect common forms of prey ... BMC Ecology found that birds will target salamanders that ... response to alterations in the ratio of a distinguishing trait. ... with Kim Shook and Reuben Izally to study the effects ...
... and Hosting Services Enhances Law Enforcement Information SharingWALL, ... Bulletin Board: BKYI), a leader in finger-based biometric ... a strategic partnership with Nlets. Nlets is the ... network for the exchange of law enforcement, criminal ...
... scientists report for the first time on the only known ... frequencies are too high to be heard by humans. Known ... only on the Southeast Asian island of Borneo. , ... frequency, which exceeds the upper limit of sounds detectable by ...
Other Biology News:BIO-key(R) Enters Strategic Partnership With Nlets 2BIO-key(R) Enters Strategic Partnership With Nlets 3UCLA scientists discover ultrasonic communication among frogs 2UCLA scientists discover ultrasonic communication among frogs 3UCLA scientists discover ultrasonic communication among frogs 4
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
EDG-6 (1)...
Complexin-1/2 (FL-134)...
... Comments: Ab-1 stains tumor cells of embryonal ... type of germ cell tumors like seminoma. Glandular ... are positive. Luminal and endocrine cells of stomach ... breast are also positive. Epitope: Carbohydrate ...
Biology Products: